Moreover, the correlation between CRNDE and PI3K/Akt/mTOR pathway was explored to identify the mechanism in regulating TMZ-resistance in glioma, which might provide a new therapeutic target for GBM treatment. The gene discussed is MTOR; the disease is central nervous system cancer.